<DOC>
	<DOCNO>NCT02096757</DOCNO>
	<brief_summary>Investigators hypothesize high-dose n-3 polyunsaturated fatty acid ( PUFA ) oral supplementation improve improve systemic inflammation patency peripheral vascular intervention ( PVI ) .</brief_summary>
	<brief_title>The Use Fish Oil Reduce Inflammation Caused Peripheral Vascular Intervention</brief_title>
	<detailed_description>The OMEGA-PVI trial double-blind , randomize ( 2:1 active : placebo ) , placebo-controlled trial 30 patient age â‰¥ 40 year PAD . Eligible patient screen accord specify inclusion exclusion criterion . All patient treat per current practice reflect American Heart Association Practice guideline PAD . n-3 PUFA supplementation achieve 4 capsule Pro-Omega twice daily ( Nordic Naturals , Watsonville , California , USA ) , correspond total 4.4g/day give prior immediately operation . Each ProOmega capsule contain 325mg EPA 225mg DHA . The placebo group take number capsule contain inactive substance ( soybean ; Nordic Naturals ) , design color shape treatment capsule . Blood draw , questionnaire , ultrasounds do periodically . Specific measurement include establish marker inflammation resolution inflammation , well ultrasound measure PVI patency . The study propose potential provide important new insight role nutritional intervention PAD , well improve outcome related surgical revascularization .</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Disabling claudication CLI indication PVI ( Rutherford Class IIV ) Objective evidence PAD e.g . ABI &lt; 0.9 , TBI &lt; 0.6 absent pedal pulse Currently take highdose n3 PUFA , define &gt; 2 g/day Able provide write informed consent AND Undergoing PVI ( catheterbased therapy ) involve aortoiliac segment , superficial femoral artery popliteal artery . Age &lt; 40 &gt; 90 year Undergoing open surgical revascularization Evidence active infection limb foot osteomyelitis Extensive tissue loss ( Rutherford Class VI Disease ) Diagnosed hypercoagulable state Nonatherosclerotic/aneurysmal disease indication procedure Chronic liver disease myopathy Endstage renal disease ( CKD 5 ) Poorly control diabetes ( HbA1C &gt; 8 % ) Recent major surgery illness within 6 week Use immunosuppressives chronic inflammatory disorder History organ transplantation Pregnancy plan become pregnant Condition patient life expectancy le one year</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Claudication</keyword>
	<keyword>Critical Limb Ischemia</keyword>
	<keyword>Endovascular procedure</keyword>
	<keyword>Atherosclerosis</keyword>
</DOC>